APA (7th ed.) Citation

J, B., S, A., HF, B., H, K., T, A., RM, C., . . . W, A. (2021). The potential use of tideglusib as an adjuvant radio-therapeutic treatment for glioblastoma multiforme cancer stem-like cells. Pharmacological reports : PR, 73(1), 227. https://doi.org/10.1007/s43440-020-00180-5

Chicago Style (17th ed.) Citation

J, Bou-Gharios, et al. "The Potential Use of Tideglusib as an Adjuvant Radio-therapeutic Treatment for Glioblastoma Multiforme Cancer Stem-like Cells." Pharmacological Reports : PR 73, no. 1 (2021): 227. https://doi.org/10.1007/s43440-020-00180-5.

MLA (9th ed.) Citation

J, Bou-Gharios, et al. "The Potential Use of Tideglusib as an Adjuvant Radio-therapeutic Treatment for Glioblastoma Multiforme Cancer Stem-like Cells." Pharmacological Reports : PR, vol. 73, no. 1, 2021, p. 227, https://doi.org/10.1007/s43440-020-00180-5.